New tools change how patients experience their own physiology.
When continuous data from a glucose monitor is combined with targeted interventions like peptides, the shift can happen so quickly it almost feels like a placebo.
The effect is real, but it raises a great question: how should these results be interpreted in a clinical context?
Listen to the full conversation in our latest episode with Lauren Colletti. Available now on Life Of Flow’s channel.
